Hussman Strategic Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Hussman Strategic Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-203,000	Closed	-$8.37M	–	245
2015 Q2	$8.37M	Hold	203,000	–	–	0.97%	43
2015 Q1	$7.15M	Buy	203,000 +144,000	+244%	+$4.87M	0.75%	52
2014 Q4	$1.9M	Hold	59,000	–	–	0.19%	120
2014 Q3	$1.66M	Buy	59,000 +9,000	+18%	+$274K	0.14%	148
2014 Q2	$1.51M	Buy	+50,000	New	+$1.38M	0.12%	130
2013 Q3	–	Sell	-116,000	Closed	-$3.33M	–	255
2013 Q2	$3.33M	Buy	+116,000	New	+$3.2M	0.15%	132

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Hussman Strategic Advisors's BRLI Position: Q3 2015 in Review

Hussman Strategic Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 203,000 shares — an estimated $8.37M sold.

Hussman Strategic Advisors first reported a position in BRLI in Q2 2013 and held it in 6 quarters. The position peaked at $8.37M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Hussman Strategic Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Hussman Strategic Advisors sold 203,000 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $8.37M.
Hussman Strategic Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 6 quarters.
Hussman Strategic Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $8.37M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Hussman Strategic Advisors's 13F filing for Q3 2015, filed 2 Nov 2015.